Neudle.com: multiple sclerosis epidemiology of

Differential
(Click to cross reference)

acetylcholine receptor

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

adverse drug reaction

algorithm

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, Parkinson-dementia-complex

analgesic

anemia

angiography, cerebral

angiography, spinal

antibodies to measles

apraxia

area postrema

area postrema syndrome

atlanto axial dislocation, congenital

autoantibodies

autoimmune disease

autonomic dysfunction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

campylobacter infection

CAT scan, abnormal

cause of death

cavernous sinus, syndrome

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebral cortex

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular disease

corpus callosum, lesion of

cost

cranial neuropathy, multiple

critical care unit

cryptococcal meningitis

cytomegalovirus infection

deep gray nuclei

delirium

dementia

demyelinating disease

diagnostic criteria

diencephalon

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disseminated intravascular coagulation(DIC)

electroencephalogram, abnormalities of

electroencephalogram, brain mapping

electroencephalogram, periodic complexes

emergencies, neurologic

employment

encephalitis

encephalitis, bornavirus

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalocele

encephalopathy

encephalopathy, metabolic

endemic area

epidemiology of neurology

ergotamine

extinction on double simultaneous stimulation

fistula, arterio-venous, dural

fistula, arterio-venous, dural, spinal

gammaglobulin therapy, intravenous

gender

gray matter

Guillain Barre syndrome

Guillain Barre syndrome, complications

Guillain Barre syndrome, differential diagnosis of

Guillain Barre syndrome, etiology of

Guillain Barre syndrome, prognosis of

head injury

head injury, management of

head injury, mild

head injury, prognosis in

headache

headache, children

headache, post traumatic

headache, severe

headache, thunderclap

headache, unilateral

heatstroke

hemangioma

heralding manifestation

herpes simplex virus

herpes virus infection

herpes zoster

hiccoughs

highly active antiretroviral therapy

Hispanics

HLA

human immunodeficiency virus type 1

hypersegmented polys

hyperthermia

hypotension, systemic

hypothalamus, lesion of

immune reconstitution inflammatory syndrome

immunization, neurologic complications with

immunocompetent

immunosuppression

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

incidence

inclusion bodies

inclusion bodies, eosinophilic intranuclear

incontinence, fecal

infantile tremor syndrome

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

Jakob-Creutzfeldt disease

JC virus

leg weakness, bilateral

life expectancy

lipoprotein receptor-related protein 4

lymphoma

lymphoma involving CNS

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

medical-legal aspects of neurology

medulla oblongata

medulla oblongata, lesion of

memory, impairment of

mental status, abnormal

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

monoclonal antibodies

mononeuropathy

mononeuropathy multiplex

mortality

motor neuron disease

motor neuron disease, juvenile form

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, diffusion weighted

MRI, field strength, high

MRI, flow void, blood

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, incidental finding

MRI, lesion burden

MRI, spinal cord

MRI, spinal cord, increased intramedullary cord signal

MRI, T1 weighted high signal foci

MRS

multiple sclerosis

multiple sclerosis, asymptomatic

multiple sclerosis, cluster

multiple sclerosis, diagnosis of

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, lesion location

multiple sclerosis, pathogenesis

multiple sclerosis, prognosis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, treatment of

muscle weakness

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myelitis

myelitis, longitudinal

myelitis, transverse

myelopathy

myelopathy, ascending

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve conduction studies

neurologic disease, diagnoses of

neurologic examination

neurologic signs

neurologic symptoms

neurologic testing

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathology, brain

neuropathy

neuropathy, sensory

nonsteroidal anti-inflammatory drug

occupational neurologic disorders

ophthalmoplegia

ophthalmoplegia, painful

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuropathy

orthostatic hypotension

periaqueductal lesion

perineum, numbness of

periodic paralysis

periodic paralysis, thyrotoxic

pernicious anemia

personality change

pertussis immunization

plasmapheresis

pleocytosis of cerebrospinal fluid

post concussive syndrome

post infectious polyneuropathy

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

proprioception, abnormal

psychological testing

psychomotor retardation

pyramidal tract dysfunction

quality of life

radicular pain

radiculitis

rapidly fatal neurologic illness

rapidly progressing neurologic illness

recurrent

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

renal failure

retrovirus

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

seizure, immunization causing

sensory loss

sensory loss, cutaneous

septicemia

serologic testing

serologic testing, false negative

spinal cord, lesion of

spinal cord, vascular malformation of

spirochete infection

steroid

steroid therapy, CNS treatment and complications with

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

syphilis, diagnosis and treatment

thalamus, lesion of

thalamus, lesion of-bilateral

tick-borne encephalitis

Tolosa Hunt syndrome

toxoplasmosis, acquired

toxoplasmosis, CNS

treatment of neurologic disorder

tremor

trigeminovascular system

urinary tract infection

vaccination, neurologic complications with

vaccine

vasospasm

vasospasm, cerebral

vibratory sensation, abnormal

visuospatial disturbance

vitamin deficiency

vomiting, intractable

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weight loss

white matter disease

white matter disease, periventricular

work loss

zinc

Showing articles 950 to 1000 of 4480 << Previous Next >>

The 5-Year Risk of MS After Optic Neuritis
Experience of the Optic Neuritis Trtm Trial, Optic Neuritis Study Group, Neurol 49:1404-1413997., , 1997

Risk Factors for Developing Multiple Sclerosis after Childhood Optic Neuritis
Neurol 49:11413-1418, Lucchinetti,C.F.,et al, 1997

Herpes Simplex Encephalitis Treated with Acyclovir:Diagnosis and Long Term Outcome
JNNP 63:321-326, McGrath,N.,et al, 1997

Cerebral Manifestation of Erdheim-Chester Disease:Clinical and Radiologic Findings
Neurol 49:1702-1705, Bohlega,S.,et al, 1997

Idiopathic Granulomatous Angiitis of the CNS Manifesting as Diffuse White Matter Disease
Neurol 49:1696-1699, Finelli,P.F.,et al, 1997

Myocardial Ischemia with Normal Coronary Arteries Associated with Thoracic Myelitis
NEJM 337:1920, Lalouschek,W.,et al, 1997

A Case-Control and Nerve Biopsy Study of CREST Mutliple Mononeuropathy
Neurol 49:1641-1645, Dyck,P.J.B.,et al, 1997

Trigeminal Neuralgia in Patients with Multiple Sclerosis:Lesion Localization with magnetic Resonance Imaging
Neurol 49:1142-1144, Gass,A.,et al, 1997

The Quality-of-Life Effects of Interferon Beta-1b in MS
Arch Neurol 54:1475-1480, Schwartz,C.E.,et al, 1997

Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997

Chromosome 19 Single-Locus & Multilocus Haplotype Assoc with MS, Evid of New Suscept Locus in Caucasian & Chinese Pts
JAMA 278:1256-1262, 12821997., Barcellos,L.F.,et al, 1997

Unusual Causes of Headache
Neurol 48:1494-1499, Ramadan,N.M., 1997

Strong Clustering and Stereotyped Nature of Notch3 Mutations, in CADASIL Patients
Lancet 350:1511-1515, 14901997., Joutel,A.,et al, 1997

Multiple Sclerosis, Depression, and Suicide
BMJ 315:691-692, Feinstein,A., 1997

Multiple Sclerosis Lesion Detection in the Brain:A Comparison of FLAIR & Conventional T2-Weighted Dual Spin Echo
Neurol 49:364-370, Gawne-Cain,M.L.,et al, 1997

Ischemic Lesion Volumes in Acute Stroke by Diffusion-Weighted MRI Correlate with Clinical Outcome
Ann Neurol 42:164-170, Lovblad,K-O.,et al, 1997

Clinical Characteristics of Patients with Motor Disability Due to Conversion Disorder:A Prospective Study
JNNP 63:83-88, Binzer,M.,et al, 1997

Epstein-Barr Virus Encephalomyelitis Diagnosed by Polymerase Chain Reaction:Detection of the Genome in the CSF
Neurol 48:1351-1355, Tselis,A.,et al, 1997

Lymphoproliferative Disorders and Motor Neuron Disease:An Update
Neurol 48:1671-1678, Gordon,P.H.,et al, 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997

A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Influenza Immunizaation in MS
Neurol 48:312-314, Miller,A.E.,et al, 1997

HLA Typing in Acute Optic Neuritis, Relation to MS & Magnetic Resonance Imaging Findings
Arch Neurol 54:76-80, Frederiksen,J.L.,et al, 1997

Correlation of Clinical, Magnetic Resonance Imaging, and Cerebrospinal Fluid Findings in Optic Neuritis
Ann Neurol 41:392-398, Jacobs,L.D.,et al, 1997

Volumetric MRI Analysis Comparing Subjects Having Attention-Deficit Hyperactivity Disorder with Normal Controls
Neurol 48:589-601, Filipek,P.A.,et al, 1997

Neuroanatomy in Rett Syndrome:Cerebral Cortex and Posterior Fossa
Neurol 48:399-407, Subramaniam,B.,et al, 1997

Longitudinal Change in Basal Ganglia Volume in Patients with Huntington's Disease
Neurol 48:394-399, Aylward,E.H.,et al, 1997

Medial Temporal Lobe Volumetrics in Traumatic Brain Injury
AJNR 18:25-28, Jack,C.R.,et al, 1997

Multiple Sclerosis Presenting as Transverse Myelopathy:Clinical and MRI Features
Neurol 48:65-73, Simnad,V.I.,et al, 1997

Cavernous Angioma of the Brain Stem Mimicking Multiple Sclerosis
NEJM 336:875-876, Vrethem,M.,et al, 1997

Clinicopath Conf
Oligodendroglioma, Mixed with Low-Grade Astrocytoma, Multiple Sclerosis, Case 12-1997, NEJM 336:1163, 11717., 1997

Concurrence of Multiple Sclerosis and Brain Tumor:Clinical Considerations
Neurol 48:1330-1333, Khan,O.A.,et al, 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Offspring Recurrence Rates and Clinical Characteristics of Conjugal Multiple Sclerosis
Lancet 349:1587-1590, Robertson,N.P.,et al, 1997

Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997

Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997

The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997

Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997

Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997

Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Arch Neurol 54:1012-1015, Constantinescu,C.S.,et al, 1997

Hemiageusia:An Unusual Presentation of Multiple Sclerosis
JNNP 54:657, Pascual-Leone,A.,et al, 1997

Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997

Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997

Frequency and Significance of Antinuclear Antibodies in Multiple Sclerosis
Neurol 49:857-861, Collard,R.C.,et al, 1997

Olfactory Dysfunction in Multiple Sclerosis
(Letter) NEJM 336:1918-1919997., Doty,R.L.,et al, 1997

Assessment of Olfaction in Multiple Sclerosis:Evidence of Dysfunction by Olfactory Evoked Response and Identification Tests
JNNP 63:145-151, Hawkes,C.H.,et al, 1997

Paramedian Pontine Infarction
Stroke 28:809-815, Kataoka,S.,et al, 1997

Showing articles 950 to 1000 of 4480 << Previous Next >>